We are happy to announce the official release of first issue of IJAR, IJCRD Journals. Please visit IJAR-Issue1, IJCRD-Issue1 page for respective articles. We would like to express our sincere thanks for your support. ×

About Us

Nuclei Online is an Open Access publisher on the way to be the world leader in the provision of STM (Science, Technology and Medicine) Open Access content. As a publisher, Nuclei Online aims to disseminate knowledge and create an archive of literature for the field. 

Connect

At Nuclei Online, we believe socializing the open access publishing model helps in accelerating scientific developments. You can interact with your fellow authors by visiting their profile page depending on their privacy settings.
                             know more…

Why Open Access?

Open Access is a publishing model which allows readers to access scientific publications online free of charge. Nuclei Online felicitates and encourages Open Access. Our aim is to spread knowledge and allow readers from around the world to contribute in building knowledge banks bypassing all the barriers.

Features

Publishing Formats

Multiple Formats

Articles are published in multiple formats such as PDF, Text.
Socialize

Connect

Let your work reach to more people and access all your published articles at one place through Connect.
Editors

Editorial Board

Reputed Scientists and Scholars on the Editorial Board..
Others

Other Features Include

Quick processing and publication. Provision to have a hard copy. Articles Translated in multiple languages to reach wider audience. Minimum Publication Charges. Provision for audio copy upon request to anyone.

New Articles

Biotechnology advances for a HIV/AIDS cure

Fausto Titti*, Maria T. Maggiorella and Alessandra Borsetti         Editorial  
Read More »

 

Recently joined Editors

Dr. Christine Dufès, Senior Lecturer in Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, United Kingdom. Journal: IJCRD
Dr. Omar Sued,  Director, Clinical Research, FundacionHuesped, Argentina. Journal: IJAR
Dr. Amani Abd EL-Hamid El-Basmy, Chairman, Epidemiology and Cancer registry unit, Kuwait cancer Control center. Ministry of health, Kuwait. Journal: IJCRD
Dr. Emina Malisic,  Assistant Research Professor, Laboratory for Molecular genetics, Department of experimental oncology. Institute for Oncology and Radiology of Serbia, Serbia. Journal: IJCRD
Dr. Alejandro Sosnik, Assistant Professor, Department of Pharmaceutical Technology, University of Buenos Aires, Argentina. Journal: IJAR
Dr. Chae-Ok Yun, Professor, Department of Bioengineering, College of Engineering, Hanyang University, Korea. Journal: IJCRD
Prof. Guy Storme, Head of Department, Radiation Oncology, UZ Brussel, Belgium. Journal: IJCRD
Dr. Ajay Goel, Director, Epigenetics and Cancer Prevention, Baylor Research Institute, Baylor University Medical Center, USA. Journal: IJCRD
Dr. Gurudutt N. Pendyala, Instructor, Developmental Neuroscience Department, Munroe-Meyer Institute, University of Nebraska Medical Center, USA. Journal: IJAR

 

 

Connect